Amphetamine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Amphetamine Extended-Release Tablets in the Treatment of Adults With ADHD
Condition:   ADHD Interventions:   Drug: AMPH ER Tab 5, 10, 15 and 20 mg;   Drug: AMPH ER Tab Matching Placebo 5, 10, 15 and 20 mg Sponsors:   Tris Pharma, Inc.;   Premier Research Group plc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2019 Category: Research Source Type: clinical trials